Search PubMed⌕ Search

Biomedical subjects

L Hahn

Publications and source records attributed to L Hahn.

At least 55 records · Page 3Linked to original sources
PubMed1981

Premenstrual complaints II. Influence of oral contraceptives.

The prevalence of individual premenstrual symptoms was studied in a randomly selected group of 217 women taking oral contraceptives (OC). The results were compared with corresponding data from 595 women not using the pill. the analyses included six different mental and somatic symptoms defined and graded in severity and related to age. It was found that OC had a beneficial effect on the premenstrual tension symptoms (PMT) in all age groups except in the youngest group (18 years), in which the tendency was rather the opposite. Within the total sample of women, users of OC were significantly less frequently absent from work. The present results are in agreement with those of most earlier studies, provided that age is taken into account.

Absenteeism↗
PubMed1979

The influence of acetylsalicylic acid and paracetamol on menstrual blood loss in women with and without an intrauterine contraceptive device.

The influence of ASA and paracetamol on menstural blood loss and on some hematologic parameters was investigated in 23 women without an IUD and 10 women with an IUD. Neither in women with normal nor in women with small defects in the hemostatic mechanism were statistically significant increases in menstrual blood losses observed during treatment with ASA or paracetamol when compared to placebo. There was no linear correlation between bleeding time and basal menstrual blood loss or between the blood losses induced by ASA and paracetamol and the bleeding time.

Acetaminophen↗
PubMed1979

Hormone profile in premenstrual tension: effects of bromocriptine and diuretics.

Plasma levels of prolactin, FSH, LH, progesterone and 17-beta-oestradiol in twenty women with premenstrual tension were compared with those in twenty controls. The former group was studied also during treatment with bromocriptine. The mean prolactin level in the PMT group was lower in the follicular phase than in the luteal phase (P less than 0.01), but there was no difference between the PMT and control group in the luteal phase. No differences were found between the controls and the PMT group in FSH,LH, 17-beta-oestradiol and progesterone levels in the luteal phase. Bromocriptine suppressed prolactin concentrations (P less than 0.01), but had no effect on the FSH, LH, 17-B-oestradiol or progesterone levels.

Adult↗
PubMed1978

Body water and weight in patients with premenstrual tension.

The total body water, total body potassium and weight were studied during the follicular and luteal phases of the cycle in 20 patients with severe premenstrual tension and 20 controls without symptoms. The effects of a diuretic (bumetanide) and bromocriptine were also studied in the patients with premenstrual tension. The mean body water in the premenstrual tension group did not differ significantly from that in the controls neither did the mean body potassium levels. However, during the late luteal phase the water/potassium ratio in liters per mol of potassium was significantly higher in the patients with premenstrual tension than in the controls. In the women with premenstrual tension the body water values varied more widely between the luteal phase and follicular phase than in the controls. The mean body water and weight in the premenstrual tension group were similar in the late luteal and early follicular phases. Treatment with bumetanide or bromocriptine had no effect on the parameters studied.

Adult↗
PubMed1977

Influence of acetylsalicylic acid and paracetamol on menstrual blood loss.

In a double-blind cross-over study the influence of acetylsalicylic acid (ASA) and paracetamol on menstrual blood loss has been investigated in 23 women without an intrauterine loop or birth control pills. After intake of ASA there was no significantly, increased blood loss compared with intake of placebo or paracetamol.

Acetaminophen↗
PubMed1977

Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle.

The variations in the number of platelets, platelet retention, blood coagulation, fibrinolysis and various plasma proteins were studied during the menstrual cycle in 30 normal women. Blood samples were taken on 6 occasions; day 1, 2, and 3 of menstruation, day 5-9 (follicular phase), day 12-16 (around ovulation), and day 19-23 (luteal phase), respectively. The concentration of fibrinogen was lower during menstruation than in the luteal phase. Factor II-VII-X and platelet retention were lowest and the recalcification time was shortest during the menstruation. The number of platelets was highest in the ovulatory phase. The fibrinolytic activity was higher in the luteal phase and during the menstruation than in the follicular phase. The results might indicate an intrauterine clotting during the menstruation. The close correlations between the variations of most of the plasma proteins indicate the presence of some general not identified factor which is probably not the variation in the intravascular water content.

Adult↗
PubMed1976

Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss.

A group of women with excessive menstrual blood loss (menorrhagia) without any known local or general underlying disease was studied and compared to a group of women with normal menstrual blood loss. Blood coagulation, platelet function and fibrinolysis as well as a variety of plasma proteins were analyzed on six occasions during one menstrual cycle. Women with menorrhagia were found to have a slightly higher concentration of fibrinogen--fibrin degradation products, a higher factor V and VIII activity, higher antithrombin III, alpha 1-antitrypsin concentrations and higher antifibrinolytic activity than the normal women. The concentration of albumin, beta IE-globulin, orosomucoid, ceruloplasmin and IgG were lower in women with memorrhagia than in normals. The capillary fragility did not differ significantly between the groups. The observed differences in clotting factors between the groups could not have caused the differences in blood losses.

Adult↗
PubMed1976

Effect of horn flies on vanilmandelic acid excretion of dairy cattle.

This study measured a physiological effect of known horn fly (Haematoba irritans L.) population densities on dairy cattle. Urinary excretion of the catecholamine metabolite, 3-methoxy-4-hydroxy mandelic acid, was an indicator of physiological response to the parasites. Six lactating Holstein cows were acclimated to the test room prior to a 3-wk control at 21 C. Animals were then exposed to approximately 500 horn flies per cow per day for 4 wk. On days 1 and 21 of exposure, two urine samples were obtained from each cow. Mean urinary values for cows were 13.3 +/- 3.1 mug/100 ml in the control period and 18.9 +/- 3.4 mug/100 ml during fly exposure. We believe that increased vanilmandelic acid reflects an increase in standing time and nervous activity associated with the physical disturbance due to the biting of the flies.

Animals↗
PubMed1975

Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses.

Fibrinogen-fibrin degradation products, FDP, in menstrual blood during the first three days of menstrual blood during the first three days of menstruation have been investigated. Two groups of women were studied, those with normal menstrual blood loss (15 women, mean loss 30 ml, range 8-60 ml) and those with menorrhagia (14 women, mean loss 222 ml, range 107-729 ml). The following results were obtained: 1). The FDP concentrations decreased during menstruation in both groups. 2). The FDP concentrations in the two were compared for each day of the menstrual period. No differences were found between the two groups. A possible explanation of the results is given: there is a higher rate of coagulation and fibrinolysis in the endometrium of women with menorrhagia compared with women with normal blood losses. The hypothesis is supported by results of studies in which tranexamic is supported by results of studies in which tranexamic acid, an inhibitor of fibrinolysis, was given to reduce the menstrual blood loss. 3). The FDP excretion patterns differed from women to women. There were no consistent differences between the menorrhagic and the control group.

Adult↗